Hey, everybody. Welcome, Dr.

podcast. I appreciate you guys being here supporting this podcast.

We have some great guests and very interesting interviews. I hope if you have any suggestions,

by the way, send them over to contact at DrDrew.com and head over there also for after dark

and Adam and Drew and other things we're doing over there. And do not forget that streaming

show DrDrew.tv is no doubt this audience would find that material very interesting. It's

very different than all this. We're sort of me and Dr. Kelly Victory on Wednesdays. It's

again, it's three o'clock Tuesday. There's a Pacific are interviewing some of the people

that have not been heard to see what we can learn from them. Sometimes over their skis,

sometimes I learned something. But as always, that's the process. You put some on things

and take a look at what people are thinking and what the data suggests and go from there

and be very cautious and skeptical as you move forward. Today, I have Dr. Dave Rabin.

He is a psychiatrist. He's got lots of interesting things he is working on. And he and I have shared

our love of interpersonal neurobiology and all the neurobiological correlates with

addiction and situations like that. He has a very interesting, interesting instrument called

Apollo. You can follow him on Twitter and Instagram at, whoop, Dave. I get this right at Dr. David

Rabin. Am I getting that right? Yep. And Dr. is DR David Rabin. And Apollo, Apollo,

Neuro, Apollo underscore Neuro on Instagram and Apollo underscore Neuro. So today, I want to get

into some of the newer stuff that psychiatry is looking down the barrel of. I have some really

fine colleagues who are extraordinarily excited, particularly by psilocybin and some of these hallucinogens

and some of the data that's out there. I as someone that has worked in the world where I've seen

lots of injury from these things. They scare that they scare me until we know for sure the risk

...